Vystar Corp (PK:VYST)

Business Focus: Rubber Plantation

Sector:  Consumer Cyclicals Industry:  Tires & Rubber Products
See Regulatory Filings on SEC
Company Contact
Address: 101 Aylesbury Rd
WORCESTER MA 01609-1257
Tel: N/A
Website: N/A
Key People
Steven Rotman
Chief Executive Officer, Director
Business Overview
Vystar Corporation is the creator and owner of the technology to produce Vytex Natural Rubber Latex (NRL). The Company's technology reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The Company operates in two segments: Vytex Division and Kiron Division. The Vytex Division is focused on expanding the licensing and utilization of its source natural rubber latex technology. Its Kiron Division provides sleep medicine services, including clinical and diagnostic. The Company's products and services include Natural Rubber Latex, and Clinical Sleep Diagnostics and Durable Medical Equipment. Its product portfolio includes Vytex NRL in high ammonia (HA) and low ammonia (LA) formulations. Vytex NRL is produced at the latex processor level and can be integrated into the processing environments. Vytex NRL is produced at the latex processor level and can be integrated into various processing environments.
Financial Overview
For the three months ended 31 March 2019, Vystar Corp revenues increased from $4K to $192K. Net loss increased 69% to $3.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Stock-based Compensation in SGA increase of 15% to $1.6M (expense), Interest expense increase from $41K to $100K (expense).
Employees: 13 as of Dec 31, 2013
Reporting Currency: U.S. Dollars
Enterprise value: $38.44M as of Mar 31, 2019
Annual revenue (TTM): $0.53M as of Mar 31, 2019
EBITDA (TTM): -$3.71M as of Mar 31, 2019
Net annual income (TTM): -$6.68M as of Mar 31, 2019
Free cash flow (TTM): -$1.60M as of Mar 31, 2019
Net Debt Last Fiscal Year: $2.00M as of Mar 31, 2019
Shares outstanding: 1,041,103,892 as of Apr 22, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization